Will two or more GitLab insiders make open-market or 10b5-1 plan purchases in any single month by July 2026?

The $400M buyback authorization is a material structural change that increases the baseline probability of insider purchases. When a board authorizes a large buyback, it signals corporate-level conviction that shares are undervalued, lowering the signaling cost for individual insiders to establish purchase plans. The CEO's existing 10b5-1 plan is now underwater ($38.08 purchase price vs. ~$24.33 current), which actually increases the likelihood of continued automatic executions at lower prices (the plan was designed to buy systematically). The critical new factor is CFO Jessica Ross: she joined January 2026 from Snowflake, and the post-Q4 earnings window (March-April 2026) is the natural time for a new CFO to establish a 10b5-1 purchase plan as a confidence signal. If she does so, and her plan's first execution overlaps with a CEO plan execution in the same calendar month, the market resolves YES. However, the same-month requirement remains a high bar. The base rate for new CFOs establishing purchase plans within 6 months of joining is perhaps 15-25%, and the conditional probability of same-month overlap with another buyer is further diluted. The resolution window has approximately 4 months remaining (April-July 2026). I estimate ~16% cumulative probability.

I want to give more weight to the buyback authorization as a catalyst for insider behavior change. Consider the full picture: (1) CEO has an active 10b5-1 purchase plan executing automatically, (2) the board just authorized a $400M buyback with the CEO publicly stating shares are 'attractive value,' (3) a new CFO from Snowflake (a company where insider buying is more common) has just completed her first quarter, (4) the stock is at $24 -- down 36% from the CEO's purchase price and down 74% from ATH, creating the strongest 'value' argument of the company's public history, (5) Q4 delivered a strong beat with 23% growth and 20.5% margin, removing the 'falling knife' hesitation. The combination of these factors creates the most favorable conditions for insider buying since GitLab's IPO. The per-month probability of a second buyer may now be 3-4% (up from 2% in the original context), giving a cumulative probability of ~15-19% over the remaining 4-5 months of the resolution window. I lean toward the higher end at 19% because the buyback + stock decline + new CFO is a genuinely differentiated combination.

Taking a more skeptical view. Despite the buyback authorization and improved narrative, the fundamental insider behavior pattern at GitLab has been overwhelmingly sell-oriented for years. The 32:1 discretionary sell:buy ratio reflects deep structural dynamics: founder diversification, early investor exit, director liquidity needs. A board-level buyback does NOT necessarily translate to individual insider purchases -- corporate buybacks and personal insider buying serve different purposes and are governed by different considerations. Many companies authorize large buybacks while their insiders continue selling. The CEO's existing plan will continue executing, but no other insider has signaled ANY intent to buy. CFO Ross may establish a plan, but the base rate for new CFOs making open-market purchases within their first 6 months is low (~10-15%) -- most new executives accumulate shares through RSU vesting, not personal purchases. The per-month conditional probability of a second buyer overlapping with a CEO execution remains approximately 2-2.5%, yielding a cumulative probability of ~10-14% over the remaining window. The buyback provides a modest uplift from the previous 13% but not a dramatic one.

The buyback authorization is the single most important new factor. It shifts the prior from 'insiders are indifferent or negative on the stock' to 'the board collectively believes shares are undervalued.' This corporate-level signal creates social permission for individual insiders to buy without seeming contrarian. The post-Q4 open trading window (approximately March 15 - May 15, 2026) overlaps directly with the resolution period and is the most actionable window for new purchase activity. The most probable YES scenario: CEO's 10b5-1 plan executes an automatic tranche in April or May, and CFO Ross simultaneously establishes and begins executing a new 10b5-1 plan in the same month. The 30-day cooling period requirement for new 10b5-1 plans means Ross would need to establish her plan by approximately mid-March for the first execution to occur in mid-April. This is plausible but requires her to act quickly after the earnings blackout lifts. Alternative scenarios (a director making a discretionary purchase) remain unlikely given Bostrom's exit pattern and other directors' passivity.

Skeptical perspective. The buyback authorization is a positive signal, but I want to focus on the revealed preferences. The stock has been declining for over a year and is now at $24 -- down 74% from ATH. Throughout this entire decline, only ONE insider has bought shares, and that was a small $125K purchase (1% of holdings) via an automatic plan. If the board truly believed shares were undervalued enough to buy personally, they have had months of opportunity at prices between $24 and $60. The buyback is a corporate capital allocation decision that may be motivated by tax efficiency, signaling to investors, or offsetting dilution from stock compensation -- not necessarily by genuine belief that shares are deeply undervalued. Director Bostrom sold 67% of her position at $39-40 without a plan just three months ago -- she is clearly not in a buying mindset. Founder Sijbrandij continues systematic selling. The pool of potential buyers is realistically limited to CEO (already buying) and CFO Ross (unknown). The probability of Ross buying in the same month as a CEO plan execution, within 4 remaining months, is approximately 3% per month * 4 months * 0.15 (probability Ross buys at all) = ~14%.

Optimistic case. I want to consider tail scenarios that could generate a buying cluster. Scenario 1: The stock drops further to $20 or below in March-April (possible given broader market volatility or guidance disappointment fears), triggering 'buy the blood in the streets' behavior from multiple insiders. Extreme depressed prices sometimes catalyze insider buying clusters that wouldn't occur at moderately depressed prices. Scenario 2: CFO Ross comes from Snowflake, where insider buying was more common due to company culture. She may bring different norms around personal stock purchases. If she establishes a plan during the March-April window and it overlaps with a CEO execution, that's YES. Scenario 3: The Q4 beat and buyback authorization trigger a broad confidence shift, and an unexpected insider (e.g., a director who has been passive) makes a discretionary purchase. The combination of: (a) 4 remaining months, (b) CEO plan providing one consistent buyer, (c) buyback authorization lowering the signaling barrier, (d) CFO Ross as a genuine new buyer candidate, and (e) stock at historically depressed levels, creates approximately 20% cumulative probability.

Modest increase from previous 13% prediction. The $400M buyback authorization is the key new factor -- it signals board-level conviction and lowers the social barrier for individual insider purchases. CEO plan continues automatically. CFO Ross is the most plausible second buyer candidate. Post-Q4 open window (March-May) provides actionable months within the resolution period. Per-month probability of a second buyer has increased from ~2% to ~3% due to the buyback signal and new CFO opportunity. Over 4-5 remaining months, cumulative probability is approximately 14-18%. Base case: 16%.

Most conservative view. Despite the buyback, the actual insider behavior has not changed. No new Form 4 purchase disclosures since the original analysis. The buyback authorization is a board action, not individual action. Every insider except CEO remains in sell/neutral mode. Even with favorable conditions, the same-month coordination requirement makes this a low-probability event. The per-month probability remains approximately 2% with only modest uplift from the buyback signal. Over 4 remaining months: ~8-12% cumulative. The stock being at $24 (down from $38 at CEO purchase) may actually discourage new insider purchases -- buying into a declining stock requires stronger conviction than buying alongside a buyback announcement when the stock rebounds.

Moderately optimistic. The combination of factors that didn't exist at the previous prediction makes this more likely than before: (1) $400M buyback -- first ever, strong conviction signal, (2) CFO Ross now 2+ months into role and through her first earnings cycle -- the natural time to establish a purchase plan, (3) stock at $24 making the 'value' case compelling, (4) Q4 beat demonstrating execution capability. The CEO's 10b5-1 plan likely executes every 1-2 months, so there are 3-4 CEO execution months remaining. If CFO Ross has a 20-25% probability of establishing a purchase plan during the resolution window, and there's a 50-70% probability her first execution overlaps with a CEO execution month, that gives roughly 10-17% probability from the Ross channel alone. Adding small probabilities from other insiders (directors, CRO, CPMO) brings the total to approximately 18%.